DK32089A - Antigent syntetisk polypeptid, receptormolekyle, der kan immunoreagere dermed, diagnostisk analysesystem til bestemmelse af hbxag, samt fremgangsmaader til bestemmelse af hbxag og anti-hbxag-antistoffer. - Google Patents

Antigent syntetisk polypeptid, receptormolekyle, der kan immunoreagere dermed, diagnostisk analysesystem til bestemmelse af hbxag, samt fremgangsmaader til bestemmelse af hbxag og anti-hbxag-antistoffer.

Info

Publication number
DK32089A
DK32089A DK032089A DK32089A DK32089A DK 32089 A DK32089 A DK 32089A DK 032089 A DK032089 A DK 032089A DK 32089 A DK32089 A DK 32089A DK 32089 A DK32089 A DK 32089A
Authority
DK
Denmark
Prior art keywords
hbxag
determining
antistoff
antigent
immuno
Prior art date
Application number
DK032089A
Other languages
English (en)
Other versions
DK174060B1 (da
DK32089D0 (da
Inventor
Ann M Moriarty
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK32089D0 publication Critical patent/DK32089D0/da
Publication of DK32089A publication Critical patent/DK32089A/da
Application granted granted Critical
Publication of DK174060B1 publication Critical patent/DK174060B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/02—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK198900320A 1987-05-26 1989-01-25 Antigent syntetisk polypeptid, vandopløselig eller vanddispergerbar polymer indeholdende polypeptidet, receptormolekyle, der kan immunoreagere dermed, diagnostisk analysesystem til bestemmelse af HBxAg, samt fremgangsmåder til bestemmelse..... DK174060B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/054,424 US4942125A (en) 1984-09-07 1987-05-26 SV40 expression vector containing HBxAg as an expression marker
US5442487 1987-05-26
US8801719 1988-05-24
PCT/US1988/001719 WO1988009340A1 (en) 1987-05-26 1988-05-24 A SV40 EXPRESSION VECTOR CONTAINING HBxAg AS AN EXPRESSION MARKER

Publications (3)

Publication Number Publication Date
DK32089D0 DK32089D0 (da) 1989-01-25
DK32089A true DK32089A (da) 1989-03-21
DK174060B1 DK174060B1 (da) 2002-05-13

Family

ID=21990971

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198900320A DK174060B1 (da) 1987-05-26 1989-01-25 Antigent syntetisk polypeptid, vandopløselig eller vanddispergerbar polymer indeholdende polypeptidet, receptormolekyle, der kan immunoreagere dermed, diagnostisk analysesystem til bestemmelse af HBxAg, samt fremgangsmåder til bestemmelse.....

Country Status (9)

Country Link
US (1) US4942125A (da)
EP (1) EP0316425A4 (da)
JP (1) JPH02500245A (da)
KR (1) KR0127148B1 (da)
AU (1) AU614972B2 (da)
CA (1) CA1326109C (da)
DK (1) DK174060B1 (da)
FI (1) FI101966B (da)
WO (1) WO1988009340A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
EP0299242A3 (en) * 1987-06-22 1989-01-25 Medico Labs Ag Heterologous viral peptide particle immunogens
DE3841755A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
AU662304B2 (en) * 1990-10-22 1995-08-31 Fox Chase Cancer Center DNA construct for providing RNA therapy
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker

Also Published As

Publication number Publication date
FI101966B1 (fi) 1998-09-30
EP0316425A1 (en) 1989-05-24
WO1988009340A1 (en) 1988-12-01
US4942125A (en) 1990-07-17
AU1805088A (en) 1988-12-21
CA1326109C (en) 1994-01-11
JPH02500245A (ja) 1990-02-01
KR890701623A (ko) 1989-12-21
FI890373A (fi) 1989-01-25
DK174060B1 (da) 2002-05-13
EP0316425A4 (en) 1991-03-20
FI101966B (fi) 1998-09-30
AU614972B2 (en) 1991-09-19
DK32089D0 (da) 1989-01-25
KR0127148B1 (ko) 1997-12-29
FI890373A0 (fi) 1989-01-25

Similar Documents

Publication Publication Date Title
DE3789724D1 (de) System zur Prüfung von interaktiver Software.
DK499582A (da) Bicykliske forbindelser, fremgangsmaade til fremstilling deraf samt af farmaceutiske praeparater indeholdende disse forbindelser
DE3853014D1 (de) Apparat zur Prüfung von Einkäufen.
DK268385D0 (da) Lysfoelsomme mikrokapsler og lysfoelsomt materiale, indeholdende disse, samt anvendelse deraf til dannelse af flerfarvede billeder
DE3850178D1 (de) Strömungsmesssystem.
NO881514L (no) Overvaakningssystem for flerfaset petroleumsstroem samt tilhoerende fremgangsmaate.
DE3851909T2 (de) Flüssigkeitseinspritzsystem.
NO891818L (no) T4-reseptor-protein, relaterte dna-sekvenser samt fremstilling derav.
DK631986A (da) Fremgangsmaade samt apparat til kalcinering.
DK41590D0 (da) Forbedrede protein c-molekyler samt fremgangsmaade til fremstilling og aktivering af samme
DK32089D0 (da) Antigent syntetisk polypeptid, receptormolekyle, der kan immunoreagere dermed, diagnostisk analysesystem til bestemmelse af hbxag, samt fremgangsmaader til bestemmelse af hbxag og anti-hbxag-antistoffer.
DE3689948T2 (de) Monoklonale antikörper und testverfahren.
DE58902270D1 (de) Atemanalysesystem.
IT8223547A0 (it) Struttura di ago e sistema di serraggio.
DE3887053T4 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.
DE3853560T2 (de) Analytisches Element zur Vollblutuntersuchung.
DK467888A (da) Fremgangsmaade til fiksering af et antigen eller antistof samt et protein paa en baerer, saaledes overtrukket baerer og dens anvendelse.
NO161684C (no) Endoproteinase-lyste f or utvinning av enzymet, samt anvendelse av enzymet til sekvensbestemmelse av proteiner og peptider.
DE3785175T2 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
ATE154395T1 (de) Monoklonale antikörper
NO163069C (no) Doer med lydisolerende innlegg og framgangsmaate til framstilling av denne.
DE3886032T2 (de) Hiv-1-verwandte polypeptide, diagnosesysteme und testverfahren.
DK31589D0 (da) Assay for begyndende diabetes, monoklonale antistoffer til anvendelse herved og saet til anvendelse hertil.
IT7831335A0 (it) Procedimento e sistema per determinare la fenol-sulfon-ftaleina.
ATE100110T1 (de) Stlv-iii-verwandte polypeptide, diagnosesysteme und testmethoden.

Legal Events

Date Code Title Description
PUP Patent expired